Valeant Pharmaceuticals International, Inc. (NYSE:VRX) was amid the mix trends movers as shares knock down -1.88% to $30.25. Two groups filed a suit Valeant Pharmaceuticals International Inc. in a proposed class-action court case Monday, claiming the firm’s relationship with specialty mail-order pharmacy Philidor Rx Services was illegal and allowed Valeant to overcharge and wrongly charge for …